$45.03
Today
as of Jul 22, 16:54 ET
Last 30 days
Recent Press Releases & News
Sionna Therapeutics Insider Sold Shares Worth $3,854,281, According to a Recent SEC Filing
Sionna Therapeutics Insider Sold Shares Worth $446,862, According to a Recent SEC Filing
Assessing Sionna Therapeutics (SION) Valuation After A Mixed Period For Recent Share Price Returns
Overview
52-week range
$14
$48
90% of range
Avg surprise (last 3)
-4.5%
Avg reaction (last 2)
-3.1%
50% positive
Latest IV / EM
291%
EM ±66.6% · $45 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-0.60 | $-0.52 | -15.4% | +3.2% | -10.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.46 | — | — | — | — | financials |
| Mon Aug 11, 2025 | Jun/2025 | $-0.41 | $-0.68 | +39.7% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.62 | $-0.45 | -37.8% | — | +4.7% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-5.67 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-2710.00 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-3840.00 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 10, 2026 | Jun/2026 | OTHER | -$0.64 | -$0.41 | -56.1% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-30M | — | $-24M | $-22M | $-20M | — | $-28M | $-11M |
| Net income | $-27M | — | $-20M | $-18M | $-16M | — | $-25M | $-9M |
| EPS (diluted) | $-0.60 | — | $-0.46 | $-410.00 | $-0.62 | — | $-5.67 | $-2710.00 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $63M | $58M | $51M | $41M | $83M | $38M | $36M | $44M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $221M | $241M | $252M | $267M | $274M | $151M | — | — |
| Total assets | $305M | $326M | $339M | $352M | $370M | $186M | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $17M | $19M | $18M | $16M | $18M | $19M | — | — |
| Total equity | $288M | $307M | $322M | $336M | $352M | $-164M | $-149M | $-134M |